Behndig Anders, Eriksson Anders
Department of Clinical Science/Ophthalmology, Umeå University Hospital, Umeå, Sweden.
Acta Ophthalmol Scand. 2004 Apr;82(2):144-7. doi: 10.1111/j.1600-0420.2004.00241.x.
To evaluate surgical performance using intracameral mydriatics (ICM) in phacoemulsification surgery in a series of consecutive cases.
In a series of 198 consecutive procedures 50-200 microl of cyclopentolate 0.1%, phenylephrine 1.5% and lidocaine 1% was given intracamerally for mydriasis and anaesthesia. The previous 198 cases, dilated with topical mydriatics, were studied for comparison. Several pre- intra- and postoperative parameters were registered, and the subjective surgical performance was graded after each procedure. In 41 consecutive cases, the change in pulse and oxygen saturation induced by the ICM injection was registered.
No increase in operation time or complication rates was seen with ICM, compared to when standard topical mydriatics were used. The subjective surgical performance was ranked as equally good for both groups.
From this clinical evaluation, our impression is that ICM performs well in routine phacoemulsification surgery.
在一系列连续病例中评估前房内散瞳剂（ICM）在白内障超声乳化手术中的手术效果。
在连续的198例手术中，前房内注射50 - 200微升0.1%的环喷托酯、1.5%的去氧肾上腺素和1%的利多卡因用于散瞳和麻醉。对之前用局部散瞳剂散瞳的198例病例进行研究以作比较。记录了几个术前、术中和术后参数，并在每次手术后对主观手术效果进行评分。在连续41例病例中，记录了ICM注射引起的脉搏和血氧饱和度变化。
与使用标准局部散瞳剂相比，ICM并未增加手术时间或并发症发生率。两组的主观手术效果评分相当。
从这项临床评估来看，我们的印象是ICM在常规白内障超声乳化手术中表现良好。
